10 Studies From 2016 Further Confirming The Benefits Of Cannabis – DEA Ignores

‘The Drug Enforcement Administration (DEA) recently reneged on their latest promise to reschedule cannabis and remove it from the list of schedule I drugs, which are classified as having ‘a high potential for abuse and the potential to create severe psychological and/or physical dependence.’
“Schedule I drugs, substances, or chemicals are defined as drugs with no currently accepted medical use and a high potential for abuse. Some examples of Schedule I drugs are: heroin, lysergic acid diethylamide (LSD), marijuana (cannabis), 3,4-methylenedioxymethamphetamine (ecstasy), methaqualone, and peyote…”
Possession, production and trafficking of drugs with this classification are typically the most severely punished by federal law, and advocates of medical cannabis have been demanding for years that the DEA acknowledge the ever-growing body of legitimate scientific research and anecdotal evidence proving that cannabis does not in any way fit the description of a schedule I substance.’
Read more: 10 Studies From 2016 Further Confirming The Benefits Of Cannabis – DEA Ignores